Fundraising FoxCarnegie Mellon University — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Noveome Biotherapeuticsnoveome.cominApr 2019 · $15M
Noveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing.
BiotechHealthtechMedical DevicesPittsburgh, US
Patrick Welch(Executive Officer)Gretchen Kraemer(Executive Officer)inWilliam Golden(Executive Officer, Director)inA. Clarke Atwell(Executive Officer, Director)inKarin Potoka(Executive Officer)inLarry Brown(Executive Officer)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.